Clinical Trials Logo

Clinical Trial Summary

Two doses of relaxin will be compared to placebo for the treatment of patients with decompensated CHF


Clinical Trial Description

Pilot clinical data suggest that recombinant human relaxin may be effective in treating patients with decompensated CHF. This study will randomize patients in blinded manner to one of two doses of intravenous relaxin or placebo. Serial evaluations will include cardiac and renal function, as well as safety and tolerability. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00406575
Study type Interventional
Source Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Contact
Status Terminated
Phase Phase 2
Start date November 2006
Completion date January 2007

See also
  Status Clinical Trial Phase
Terminated NCT01831713 - Pulmonary Blood Flow Measurements in CHF Patients N/A
Withdrawn NCT01744210 - Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure N/A
Completed NCT00211874 - Improving Heart Failure Care in Minority Communities N/A
Completed NCT01960907 - Clinical Trials for Elderly Patients With Multiple Disease N/A
Completed NCT00309764 - CHF Management Using Telemedicine N/A
Completed NCT02034045 - Expanding Paramedicine in the Community N/A
Completed NCT01855022 - A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response N/A
Completed NCT02983812 - Developing Enhanced Prediction Models
Completed NCT01044290 - Outlook Quality of Life Intervention Study N/A
Completed NCT00734045 - Prospective Evaluation of the StatusFirstâ„¢ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples N/A
Not yet recruiting NCT01414439 - Group Psychotherapy Among Congestive Heart Failure Patients N/A
Approved for marketing NCT00528320 - Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System N/A